The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections.

Meng, Rui et al.·BMC cardiovascular disorders·2025·
RPEP-125382025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections.
Published In:
BMC cardiovascular disorders, 25(1), 185 (2025)
Database ID:
RPEP-12538

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-12538·https://rethinkpeptides.com/research/RPEP-12538

APA

Meng, Rui; Li, Xiangnan; Liu, Huimin; Yi, Zhong; Han, Yalei; Xie, Qing; Xiu, Helu; Yao, Fei; Guo, Na; Yu, Yan. (2025). The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections.. BMC cardiovascular disorders, 25(1), 185. https://doi.org/10.1186/s12872-025-04609-8

MLA

Meng, Rui, et al. "The comparative study of the efficacy of recombinant human brain natriuretic peptide combined with vasoactive medications for elderly patients with heart failure and hypotension receiving injections.." BMC cardiovascular disorders, 2025. https://doi.org/10.1186/s12872-025-04609-8

RethinkPeptides

RethinkPeptides Research Database. "The comparative study of the efficacy of recombinant human b..." RPEP-12538. Retrieved from https://rethinkpeptides.com/research/meng-2025-the-comparative-study-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.